Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Urticaria vasculitis and sulfone, a case report].

G Wozel, B Thiele

    Zeitschrift Fur Hautkrankheiten
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mutational landscape reflects the biological continuum of plasma cell dyscrasias.

    Blood cancer journal·2017
    Same author

    Evidence for the founder effect of a novel ACVRL1 splice-site mutation in Hungarian hereditary hemorrhagic telangiectasia families.

    Clinical genetics·2016
    Same author

    Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2).

    The British journal of dermatology·2013
    Same author

    [A decade of biologics in dermatology].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2012
    Same author

    Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.

    Clinical and experimental immunology·2011
    Same author

    Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).

    The British journal of dermatology·2011

    Dapsone effectively treated urticarial vasculitis (UV) in a patient unresponsive to other therapies. This finding highlights dapsone as a potential treatment option for steroid-refractory UV, improving clinical symptoms and normalizing complement levels.

    Area of Science:

    • Immunodermatology
    • Rheumatology
    • Pharmacology

    Background:

    • Urticarial vasculitis (UV) is often managed with systemic corticosteroids.
    • Alternative therapies are needed when steroids are contraindicated or ineffective.

    Observation:

    • A female patient with UV and metabolic syndrome showed no response to indomethacin, H1/H2 antagonists, or colchicine.
    • The patient was subsequently treated with dapsone.

    Findings:

    • Dapsone treatment led to rapid improvement in clinical symptoms of urticarial vasculitis.
    • Hypocomplementemia, a marker of disease activity, normalized following dapsone therapy.

    Implications:

    • Dapsone represents a viable therapeutic option for refractory urticarial vasculitis.

    Related Experiment Videos

  • Further research into the mechanisms of sulphones in treating UV is warranted.